(S1 (S (S (NP (NN E) (NN mu-bcl-2) (NN transgene)) (VP (VBZ facilitates) (NP (NP (JJ spontaneous) (NN transformation)) (PP (IN of) (NP (NP (JJ early) (ADJP (ADJP (JJ pre-B)) (CC and) (ADJP (JJ immunoglobulin-secreting))) (NNS cells)) (CONJP (CC but) (RB not)) (NP (NN T) (NNS cells))))))) (. .)))
(S1 (S (S (S (VP (TO To) (VP (VB assess) (NP (NP (DT the) (JJ lymphoid) (JJ tumorigenic) (NN potential)) (PP (IN of) (NP (NN bcl-2))))))) (, ,) (NP (NP (NNS mice)) (PP (IN of) (NP (NP (CD five) (JJ independent) (NNS strains)) (VP (VBG expressing) (NP (DT a) (NN bcl-2) (NN transgene)) (PP (IN in) (NP (NP (NP (NN B)) (CC and/or) (NP (NN T))) (NNS cells))))))) (VP (VBD were) (VP (VBN monitored) (PP (IN for) (NP (NN disease))) (PP (RP up) (TO to) (NP (NP (CD 12) (NNS months)) (PP (IN of) (NP (NN age)))))))) (. .)))
(S1 (S (S (NP (NN Lymphoma) (NN prevalence)) (VP (VBD was) (ADJP (ADJP (JJ minimal) (PP (IN in) (NP (DT the) (NN T) (NN lineage)))) (CC but) (ADJP (JJ significant))) (, ,) (SBAR (IN although) (S (ADJP (ADJP (JJ low)) (PRN (-LRB- -LRB-) (NP (CD 3-15) (NN %)) (-RRB- -RRB-))))) (, ,) (PP (IN in) (NP (DT the) (NN B) (NN lineage))))) (. .)))
(S1 (S (S (NP (NP (DT The) (JJ principal) (NNS types)) (PP (IN of) (NP (NNS tumors)))) (VP (VBD were) (NP (NP (NNS plasmacytomas)) (PP (VBG secreting) (NP (NP (NN immunoglobulin)) (CC and) (NP (JJ novel) (NNS lymphomas)))) (SBAR (WHNP (WDT that)) (S (VP (VBD expressed) (NP (NP (NP (NP (NNS markers)) (PP (JJ such) (IN as) (NP (NN Sca-1)))) (, ,) (NP (NP (NN CD4)) (, ,) (NP (NN Thy-1)) (, ,) (NP (NN CD34)) (CC and) (NP (NN CD45-LRB-B220-RRB-))) (, ,)) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT an) (NN origin)) (ADJP (RB very) (JJ early) (PP (IN in) (NP (JJ B-lymphoid) (NN development)))))))))))))) (. .)))
(S1 (S (S (NP (NP (NN Rearrangement)) (PP (IN of) (NP (DT the) (NN c-myc) (NN gene)))) (VP (VP (VBD was) (ADJP (JJ common)) (PP (IN in) (NP (DT the) (NNS plasmacytomas))) (, ,) (S (VP (VBG implying) (NP (NP (DT a) (JJ synergistic) (NN role)) (PP (IN for) (NP (NP (NN myc)) (CC and) (NP (NN bcl-2)))) (PP (IN in) (NP (PRP$ their) (NN etiology))))))) (, ,) (CC but) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (DT the) (NNS lymphomas))))))) (. .)))
